Bilateral Sacroiliac Joint Injection Procedure
Bilateral SI joint injections should be performed under fluoroscopic guidance using a contralateral oblique view of 5-20 degrees to superimpose the posterior and anterior joint lines, targeting the inferior aspect of the joint with approximately 1.4mL of injectate per side. 1
Image Guidance Selection
Fluoroscopy is the preferred imaging modality for SI joint injections, as it allows real-time confirmation of intra-articular needle placement and exclusion of intravascular positioning through contrast injection prior to therapeutic injectate delivery 1. While ultrasound and CT guidance are alternatives, fluoroscopy provides superior workflow and verification capabilities.
Alternative Imaging Modalities:
- Ultrasound guidance: Shows no difference in clinical outcomes compared to fluoroscopy, but has lower accuracy (50% vs 65% confirmed intra-articular placement) 1
- CT fluoroscopy: Achieves high technical success with median procedural time of 6.72 minutes for bilateral injections and low radiation exposure (0.11 mSv) 2
- 3D cone-beam CT with fluoroscopy fusion: Provides excellent accuracy with 87% achieving >50% pain relief 3
Fluoroscopic Technique - Step by Step
Patient Positioning:
- Position patient prone on fluoroscopy table
C-Arm Positioning:
- Rotate C-arm to contralateral oblique view of 5-20 degrees to superimpose the posterior and anterior SI joint lines, creating a lucency that represents the target 1
- Alternative approach: If joint lines cannot be superimposed despite exploring various oblique angles, the medial joint line may correspond to the posterior aspect of the joint 1
Target Selection:
- Target the inferior aspect of the joint (most commonly used approach) 1
- The proper puncture level is approximately 1.69 cm ± 0.63 cm above the lower edge of the joint 4
- Alternative access points (mid-portion or superior portion) are more challenging due to lack of synovium 1
Needle Insertion:
- Insert needle under fluoroscopic guidance toward the identified target
- Advance until intra-articular position is achieved
Confirmation:
- Inject contrast medium first to confirm intra-articular placement and rule out intravascular positioning 1
- Observe for contrast spread pattern
- Cephalad extension of contrast may correlate with improved short-term outcomes (2 weeks), though this advantage disappears by 8 weeks 1
Injectate Administration:
- Volume: Limit to approximately 1.4mL per joint (range 0.6-2.7mL) to avoid extra-articular spread 1
- Common therapeutic injectate: Corticosteroid (e.g., 40mg triamcinolone acetonide) with or without local anesthetic 5
- Volumes exceeding joint capacity will reach adjacent unintended structures, potentially altering outcomes 1
Bilateral Procedure Considerations
When performing bilateral injections:
- Median procedural time: 6.72 minutes (range 4.17-21.17 minutes) 2
- Radiation exposure: Median 0.11 mSv (range 0.09-0.51 mSv) for bilateral procedures 2
- Repeat the same technique for the contralateral side
- Consider staging if patient tolerance is a concern, though bilateral same-session injections are standard practice
Critical Pitfalls to Avoid
Extra-articular injection: Palpation-guided injections have poor accuracy and should not be used 1. Even with imaging, accuracy varies (fluoroscopy 65%, ultrasound 50%) 1
Excessive volume: Injecting >1.4mL risks extra-capsular spread, potentially causing transient sciatic nerve block from anterior capsular disruption 1
Patient selection error: Only 15-30% of patients with suspected SI joint pain have true SI joint pathology 1. Patients who fail to achieve positive diagnostic anesthetic block are unlikely to benefit from therapeutic corticosteroid injection 1
Skipping contrast confirmation: Without contrast verification, you cannot confirm intra-articular placement or exclude intravascular positioning
Safety Profile
Common adverse events include 1:
- Injection site pain (most common)
- Vasovagal reaction (2.5% incidence)
- Facial flushing/sweating (corticosteroid-related)
- Transient sciatic nerve block (when using local anesthetic, 6.3% in some series)
Serious complications are rare but include infection and epidural abscess in immunosuppressed patients 1. Bleeding risk is low; most guidelines recommend continuing anticoagulation 1.